CryoLife Announces First Implant Of Combination Aortic-Mitral Allograft Heart Valve At The Cleveland Clinic
CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced the first implantation of the combination aortic-mitral allograft heart valve in a patient at the Cleveland Clinic. The surgery was performed by Dr. Jose Navia, a cardiac surgeon with the Heart and Vascular Institute at the Cleveland Clinic.
More: continued here
Filed under: Cardiovascular on May 15th, 2008